![Bristol-Myers Squibb (BMS) plans to use Natera's Signatera custom circulating tumor DNA (ctDNA) assay in a Phase II study designed to assess the pharma giant’s cancer immunotherapy Opdivo (nivolumab) as an adjuvant treatment for non-small cell lung cancer (NSCLC). [Source: Eraxion/Getty]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1893-356x220.jpeg "Pre-Surgical Immunotherapy for Lung Cancer Shows Positive Results")
Rare Genetic Variant for Alzheimer’s More Common Among Icelandic Population
Research led by Icelandic Heart Association shows rare variant in TM2D3 gene linked to increased risk, earlier onset of Alzheimer's disease.
Microbiota Changes From Consumer Antimicrobial Triclosan Linked to Colitis, Colon Cancer
Triclosan, used in 2,000 consumer products from toothpaste to cosmetics, linked to altered gut microbiota, colitis, and colon cancer
Fully Automated Quality Control for Next-Gen Sequencing
The 4200 TapeStation system is a fully automated instrument that enables scientists to rapidly analyze up to 96 DNA samples at a time.
New RNA Modification Added to Epitranscriptomic Library
Scientists find modified RNA "epitranscriptome" that could be a key regulatory control of gene expression.
Single-Cell Gene Expression Patterns Provide New MS Insights
The mechanisms that underlie the progression of MS are not well understood. Now, an international, multi-institutional team of researchers has studied pathological events at...
New Variant Uncovered that Predicts Huntington’s Onset Age
Researchers at the University of British Columbia (UBC)/Centre for Molecular Medicine & Therapeutics (CMMT) and BC Children’s Hospital recently uncovered a new genetic variant...
![NGS technology has enabled researchers to epidemiologically analyze DNA sequences by quickly deciphering mass quantities of genetic information in a short amount of time. [Heart illustration: iStock/SvetaP DNA double helix: iStock/Kagenmi]](https://www.clinicalomics.com/wp-content/uploads/2019/01/304-218x150.jpeg "AdventHealth, Helix to Collaborate on Population Health Program")
AdventHealth, Helix to Collaborate on Population Health Program
Regional, non-profit healthcare delivery network AdventHealth (formerly Adventist Health System) announced it will partner with personal genomics company Helix to screen up to 10,000...
FDA Approves IND for Editas’ CRISPR Genome Editing Treatment EDIT-101
Drs. Doudna, Church among co-founders of company, which plans clinical trial with Allergan of first in vivo CRISPR genome editing treatment.
AMP, CAP Publish Consensus Guidelines for Validating NGS-Based Cancer Panels
The recommendations are designed to improve cancer care by ensuring clinical laboratories achieve high-quality sequencing results.
Liquid Biopsy Equal to Tissue to Indicate Immunotherapy Response
Liquid biopsy is just as good as traditional tumor testing at identifying microsatellite instability (MSI), an important biomarker used to predict response to immunotherapy...
